Experts explore and summarize the epidemiology of arrhythmias seen during pregnancy and in the postpartum period. The discussion includes guideline directed treatment for arrhythmias during pregnancy incorporating the safety of medications and invasive treatments, as well as recommendations for care during postpartum. 

https://bit.ly/HTDP_postpartumcareIn this episode learn how key elements from a woman's pregnancy history may impact her lifelong risk for cardiovascular disease. As patients transition in the postpartum stage, recognizing social determinants of health and incorporating counseling strategies into routine care presents an opportunity to focus on health lifestyle choices. Explore the growning field of available tools, like Life's Essential 8, to support the transition of postpartum care to the primary care setting. 

Claim CE and MOC credit: https://bit.ly/HTDP_postpartumcare

In this episode, a panel of experts discuss existing and emerging VTE (venous thromboembolism) treatment options for the complex patient, such as a patient who has been diagnosed with cancer, end stage renal disease (ESRD), chronic kidney disease (CKD), or is obese.

 Claim CE and MOC Credit at https://bit.ly/VTEHBCPX

Join our expert as they delve into the critical aspects of recognizing and diagnosing peripartum cardiomyopathy (PPCM), a serious heart condition affecting pregnant and postpartum women. This episode will cover guideline-directed medical therapy tailored for PPCM during pregnancy and the postpartum period. Additionally, postpartum care strategies will be explored along with a patient's personal journey to provide a comprehensive understanding of the condition.

The future of primary care in relation to COVID-19 in 2025 is shaped by several key trends and strategies. Join our speakers as they discuss resilience, innovation, how to utilize the most recent application of scientific findings to ensure optimal patient outcomes and much more. CE and ABIM MOC credits available: https://bit.ly/3R2wJoi

Addressing social determinants of health (SDOH) requires a multifaceted approach involving various sectors and stakeholders. There are population groups and underlying medical conditions that can increase the risk of mild to moderate COVID-19 infection, progressing to a severe outcome. The speakers will discuss these aspects and provide strategies for change.  CE and ABIM MOC credits available: 

https://bit.ly/4k0q2jY

In this episode, learn from leading experts about managing preeclampsia with and without severe features. The panel will define the pathophysiology and potential for multi-organ system impact with preeclampsia; discussion to include postpartum care recommendations. 

Claim CE and MOC credit here: https://bit.ly/ManagePreeclampsia

In this episode, hear from leading experts as they define the major health issues in hypertensive disorders of pregnancy. Learn how to outline the appropriate work-up to diagnose hypertensive disorders of pregnancy; discussion to include recommended medications as well as postpartum care.

Claim CE and MOC credit here https://bit.ly/ChronicHTN

In this episode Dr. Paul Ridker discusses the pivotal role of high-sensitivity C-reactive protein (hsCRP), a biomarker for inflammation, in cardiovascular prevention and treatment. He explains how inflammation and cholesterol together drive atherosclerosis, the significance of hsCRP testing, and the latest clinical trial findings. Dr. Ridker also highlights the importance of primary prevention strategies and the potential of targeted anti-inflammatory therapies to revolutionize cardiovascular care.

In this episode, Dr. Brittany Weber discusses the role of inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular disease. She explores the connection between inflammation and atherosclerosis and how immune system activation contributes to atherosclerosis development, the importance of endothelial damage and pro-inflammatory cytokines, and the impact of systemic inflammatory diseases on cardiovascular risk. Tune in to learn about the mechanisms behind inflammation in cardiovascular disease and the significance of hsCRP as a biomarker.